Dihydroxyphenylalanine

DBCAT000464Pharmacologic class

A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. A DrugBank category of 4 drugs. 2 of them are approved.

Also known as: 3 Hydroxy DL tyrosine · 3-Hydroxy-DL-tyrosine · 3,4 Dihydroxyphenylalanine · 3,4-Dihydroxyphenylalanine · beta Hydroxytyrosine
Drugs: Etilevodopa
Levodopa
Melevodopa
Methyldopa

What you can answer from here — as of August 24, 2016

4DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

1,630Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Dihydroxyphenylalanine share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account